Role of the Matrix Metalloproteinase and Plasminogen Activator–Plasmin Systems in Angiogenesis
Top Cited Papers
- 1 July 2001
- journal article
- other
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 21 (7) , 1104-1117
- https://doi.org/10.1161/hq0701.093685
Abstract
—Extracellular proteolysis is an absolute requirement for new blood vessel formation (angiogenesis). This review examines the role of the matrix metalloproteinase (MMP) and plasminogen activator (PA)–plasmin systems during angiogenesis. Specifically, a role for gelatinases (MMP-2, MMP-9), membrane-type 1 MMP (MMP-14), the urokinase-type PA receptor, and PA inhibitor 1 has been clearly defined in a number of model systems. The MMP and PA-plasmin systems have also been implicated in experimental vascular tumor formation, and their role during this process will be examined. Antiproteolysis, particularly in the context of angiogenesis, has become a key target in therapeutic strategies aimed at inhibiting tumor growth and other diseases associated with neovascularization.Keywords
This publication has 134 references indexed in Scilit:
- Inhibition of Angiogenesis in Vivo by Plasminogen Activator Inhibitor-1Journal of Biological Chemistry, 2001
- MMP-2 Colocalizes with Caveolae on the Surface of Endothelial CellsExperimental Cell Research, 2001
- Posttranscriptional Stimulation of Endothelial Cell Matrix Metalloproteinases 2 and 1 by Endothelioma CellsExperimental Cell Research, 2000
- Transgenic mouse models in angiogenesis and cardiovascular diseaseThe Journal of Pathology, 2000
- Antiangiogenic Activity of Restin, NC10 Domain of Human Collagen XV: Comparison to EndostatinBiochemical and Biophysical Research Communications, 1999
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitroBiochemical and Biophysical Research Communications, 1992
- Tumor necrosis factor and epidermal growth factor modulate migration of human microvascular endothelial cells and production of tissue-type plasminogen activator and its inhibitorExperimental Cell Research, 1991
- Phorbol ester induces cultured endothelial cells to invade a fibrin matrix in the presence of fibrinolytic inhibitorsJournal of Cellular Physiology, 1987
- Plasminogen Activators (Urokinase) Mediate Neovascularization: Possible Role in Tumor AngiogenesisSeminars in Thrombosis and Hemostasis, 1986